Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.61
-1.95 (-6.61%)
At close: Aug 1, 2025, 4:00 PM
27.73
+0.12 (0.45%)
After-hours: Aug 1, 2025, 7:59 PM EDT
CTI BioPharma Market Cap
Moderna has a market cap or net worth of $10.68 billion as of August 1, 2025. Its market cap has decreased by -77.74% in one year.
Market Cap
10.68B
Enterprise Value
6.24B
1-Year Change
-77.74%
Ranking
Category
Stock Price
$27.61
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $10.68B, an increase of 74.49%. That is a compound annual growth rate of 8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 11.43B | -28.55% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |